O. Gallego

发表

Characterization of seven genotypes (A to E, G and H) of Hepatitis B virus recovered from Japanese patients infected with human immunodeficiency virus type 1 (p 24-32)

M. Akashi, Katsuaki Sato, X. Wang, 2005 .

Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients.

V. Soriano, C. de Mendoza, A. Corral, 2003, AIDS.

Estimated extent of cross-resistance to ritonavir-boosted protease inhibitors among protease inhibitors-experienced patients: implications for tipranavir use.

V. Soriano, C. de Mendoza, A. Corral, 2005, AIDS patient care and STDs.

Does an Increase in Nevirapine Plasma Levels Cause Complete Virologic Suppression in Patients Experiencing Early Virologic Failure?

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2002, HIV clinical trials.

Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals.

V. Soriano, C. de Mendoza, A. Corral, 2004, Journal of virological methods.

Prevalence of drug resistance genotypes causing broad cross-resistance to nucleos(t)ide analogues

V. Soriano, A. Corral, C. Mendoza, 2004, AIDS.

Metabolic Acidosis in HIV-Infected Patients

V. Soriano, C. Mendoza, O. Gallego, 2002 .

Emergence of zidovudine resistance in HIV-infected patients receiving stavudine.

V. Soriano, C. Briones, A. Álvarez, 2000, Journal of acquired immune deficiency syndromes.

Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2004, HIV clinical trials.

High rate of resistance to antiretroviral drugs among HIV-infected prison inmates.

V. Soriano, C. de Mendoza, A. Corral, 2003, Medical science monitor : international medical journal of experimental and clinical research.

Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.

V. Soriano, J. del Romero, C. de Mendoza, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Salvage Treatment with Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients Failing All Current Antiretroviral Drug Families

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2002, HIV clinical trials.

Prediction of virological response to lopinavir/ritonavir using the genotypic inhibitory quotient.

V. Soriano, I. Jiménez-Nácher, O. Gallego, 2004, AIDS research and human retroviruses.

Prevalence of G333D/E in naive and pretreated HIV-infected patients.

B. Rodés, V. Soriano, C. de Mendoza, 2002, AIDS research and human retroviruses.

Mechanisms of resistance to antiretroviral drugs--clinical implications.

V. Soriano, C. de Mendoza, O. Gallego, 2002, AIDS reviews.

Changes in the Human Immunodeficiency Virus p7-p1-p6 gag Gene in Drug-Naive and Pretreated Patients

V. Soriano, C. de Mendoza, A. Corral, 2003, Journal of Clinical Microbiology.

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

V. Soriano, M. Leal, J. Arribas, 2001, AIDS.

Long-Term Outcome of HIV-Infected Patients with Multinucleoside-Resistant Genotypes

V. Soriano, C. Altisent, C. de Mendoza, 2003, HIV clinical trials.

Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.

B Clotet, B. Clotet, L. Ruiz, 2001, AIDS.

Relationship between drug resistance mutations, plasma viremia, and CD4+ T‐cell counts in patients with chronic HIV infection

V. Soriano, C. de Mendoza, A. Corral, 2005, Journal of medical virology.

Prevalence of novel lamivudine-resistant genotypes (E44D/A, V118I) in naive and pretreated HIV-infected individuals.

V. Soriano, C. Briones, A. Corral, 2000, Journal of acquired immune deficiency syndromes.

Rate of Virological Treatment Failure and Frequencies of Drug Resistance Genotypes among Human Immunodeficiency Virus-Positive Subjects on Antiretroviral Therapy in Spain

B. Clotet, L. Ruiz, V. Soriano, 2002, Journal of Clinical Microbiology.

Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure.

V. Soriano, C. de Mendoza, A. Corral, 2003, AIDS Research and Human Retroviruses.

Prevalence of the HIV protease mutation N88S causing hypersensitivity to amprenavir.

V. Soriano, C. de Mendoza, A. Corral, 2002, Clinical Infectious Diseases.

Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations

V. Soriano, A. Corral, I. Jiménez-Nácher, 2004, AIDS.

Prevalence of G333D/E in naive and pretreated HIV-infected patients.

B. Rodés, V. Soriano, C. de Mendoza, 2002, AIDS research and human retroviruses.